BioSpace News Archive

Ultraviolet (UV) lights and wands for home use that make unproven claims to disinfect household items against the COVID-19 virus.

NeurodigitX, the innovative digital health company, announced today a new comprehensive platform called Plastic Health™ that allows a powerful mainstream bloodless assessment of inflammation levels, first targeting the current pandemic, in an effort to supplement and enhance vaccine immunization strategies.

Invent Medical Corporation is pleased to announce the EUA approval on their HFT 150™ heated high flow system. Sam Chang, CEO comments, “After four years in development and based on multiple key opinion leaders input related to product design and features, we are poised to launch the HFT 150™ into the USA hospital markets early 2021

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

OnPoint Surgical, Inc., a privately held medical technology company pioneering Augmented Reality (AR) guidance for multiple spine, neurosurgical, and robotic procedures, today announced that Philipp Lang, Founder and CEO, will participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020.

Medline announced plans to manufacture face masks in North America for the first time.

GoMeyra, an innovative new software company dedicated to providing revolutionary tech solutions for medical laboratories, announces its roster of national labs and medical practice clients now utilizing the proprietary system, GoMeyra LIMS.

CVRx, Inc., developer of FDA-approved Barostim Therapy to treat chronic heart failure (HF), announced a CFO transition as part of the company’s long-term growth plan. Jared Oasheim, who joined CVRx in 2015, was promoted from Vice President of Finance to Chief Financial Officer (CFO)

AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that management will participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference on Tuesday, December 1, 2020.

Kala Pharmaceuticals, Inc., announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635.